IgA Vasculitis Developing during Trastuzumab Emtansine Therapy for HER2-positive Breast Cancer. Watanabe N, Yoshida S, Osano K, Ohkoshi K, et al. Intern Med 2026;65:2604-2608.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Watanabe N, Yoshida S, Osano K, Ohkoshi K, et al. IgA Vasculitis Developing during Trastuzumab Emtansine Therapy for HER2-positive Breast Cancer. Intern Med 2026;65:2604-2608.
PMID: 41780977